A multiparametric ECG score discriminated Anderson-Fabry disease from hypertrophic cardiomyopathy with a c-statistic of 0.80 (95% CI 0.74-0.86), sensitivity of 69%, and specificity of 84%.
Case-Control (n=222)
Yes
Can standard ECG parameters differentiate between Anderson-Fabry disease and hypertrophic cardiomyopathy in patients with left ventricular hypertrophy?
A standard ECG-based multiparametric score can help differentiate Anderson-Fabry disease from hypertrophic cardiomyopathy in patients with unexplained left ventricular hypertrophy.
Effect estimate: c-statistic 0.80 (95% CI 0.74-0.86)
Objectives To evaluate the role of the ECG in the differential diagnosis between Anderson-Fabry disease (AFD) and hypertrophic cardiomyopathy (HCM). Methods In this multicentre retrospective study, 111 AFD patients with left ventricular hypertrophy were compared with 111 patients with HCM, matched for sex, age and maximal wall thickness by propensity score. Independent ECG predictors of AFD were identified by multivariate analysis, and a multiparametric ECG score-based algorithm for differential diagnosis was developed. Results Short PR interval, prolonged QRS duration, right bundle branch block (RBBB), R in augmented vector left (aVL) ≥1.1 mV and inferior ST depression independently predicted AFD diagnosis. A point-by-point ECG score was then derived with the following diagnostic performances: c-statistic 0.80 (95% CI 0.74 to 0.86) for discrimination, the Hosmel-Lemeshow χ 2 6.14 (p=0.189) for calibration, sensitivity 69%, specificity 84%, positive predictive value 82% and negative predictive value 72%. After bootstrap resampling, the mean optimism was 0.025, and the internal validated c-statistic for the score was 0.78. Conclusions Standard ECG can help to differentiate AFD from HCM while investigating unexplained left ventricular hypertrophy. Short PR interval, prolonged QRS duration, RBBB, R in aVL ≥1.1 mV and inferior ST depression independently predicted AFD. Their systematic evaluation and the integration in a multiparametric ECG score can support AFD diagnosis.
Vitale et al. (Tue,) conducted a case-control in Anderson-Fabry disease and hypertrophic cardiomyopathy (n=222). Multiparametric ECG score was evaluated on Discrimination of Anderson-Fabry disease from hypertrophic cardiomyopathy (c-statistic 0.80, 95% CI 0.74-0.86). A multiparametric ECG score discriminated Anderson-Fabry disease from hypertrophic cardiomyopathy with a c-statistic of 0.80 (95% CI 0.74-0.86), sensitivity of 69%, and specificity of 84%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: